Sex Differences in the Impact of Atherosclerotic Cardiovascular Risk Burden on Cognitive Health
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.042741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Lijun Zuo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Beijing Tiantan Hospital, Beijing, Capital Medical University Beijing China. Hauptthemen laut MEDLINE: Cognition, Atherosclerosis, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Sex affects the prevalence of atherosclerotic cardiovascular disease (ASCVD) risk factors but whether sex differences exist in the associations between ASCVD risk burden and cognitive function is unclear.
Methods
This cross‐sectional study included participants from a population‐based cohort study in China that recruited community‐dwelling adults aged 50 to 75 years without baseline cardiovascular disease and stroke. The 10‐year ASCVD risk burden was quantified with 3 multivariate risk prediction equations. Cognitive domains of memory, attention, visuospatial function, executive function, and processing speed were assessed. Multivariable linear regression models were used to examine the interaction terms between sex and ASCVD risk scores on cognition.
Results
The final analytical sample included 2180 participants. Mean±SD age was 60.14 (6.38) and 52.1% were women. Men showed significantly higher ASCVD risk burden than women at baseline but the effect of ASCVD risk on 2‐year cognition were amplified in women compared with men, for the domains of memory (eg, β=−0.20 [95% CI, –0.26 to −0.13] versus β=−0.11 [95% CI, –0.16 to −0.07]), executive function (eg, β=−0.23 [95% CI, –0.31 to −0.16] versus β=−0.16 [95% CI, –0.21 to −0.10]), and processing speed (eg, β=−0.33 [95% CI, –0.39 to −0.27] versus β=−0.17 [95% CI, –0.21 to −0.13]). Sex‐stratified analyses showed different neuropsychological profiles at moderate ASCVD risk burden levels, suggesting sex‐specific ASCVD‐risk related cognitive phenotypes.
Conclusions
Sex differences in cognitive health affected by ASCVD risk underscore the importance of sex‐specific cognitive monitoring during ASCVD risk management and better vascular risk control in women to prevent cognitive decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology Beijing Tiantan Hospital, Beijing, Capital Medical University Beijing China.
- Department of Medicine Yong Loo Lin School of Medicine, National University of Singapore Singapore Singapore.
- China National Clinical Research Center for Neurological Diseases Beijing China.
- Department of Psychiatry School of Clinical Medicine, University of Cambridge Cambridge UK.
- Department of Radiology Mayo Clinic Rochester MN USA.
- Department of Neurology The Fifth Affiliated Hospital of Wenzhou Medical University Lishui Zhejiang China.
ORCID-Profile: Xuan Wang, Audrey Low, Xueli Cai, Shan Li, Yongjun Wang, Yanhong Dong, Yuesong Pan
Zitieren
APA
Zuo, L., Kua, Z., Wang, X., Low, A., Cai, X., Li, S., Wang, M., Wang, Y., Dong, Y., & Pan, Y. (2025). Sex Differences in the Impact of Atherosclerotic Cardiovascular Risk Burden on Cognitive Health. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042741
Vancouver
Zuo L, Kua Z, Wang X, Low A, Cai X, Li S, et al. Sex Differences in the Impact of Atherosclerotic Cardiovascular Risk Burden on Cognitive Health. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.042741
BibTeX
@article{Zuo2025,
author = {Zuo, Lijun and Kua, Zaylea and Wang, Xuan and Low, Audrey and Cai, Xueli and Li, Shan and Wang, Mengxing and Wang, Yongjun and Dong, Yanhong and Pan, Yuesong},
title = {Sex Differences in the Impact of Atherosclerotic Cardiovascular Risk Burden on Cognitive Health},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.042741}
}
EUVIMED